E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/16/2006 in the Prospect News Biotech Daily.

New Issue: Cerus raises $39.375 million in follow-on of 4.5 million shares at $8.75 each

By Ronda Fears

Memphis, March 16 - Cerus Corp. raised $39.375 million in gross proceeds from a follow-on offering of 4.5 million shares of common stock off the shelf priced at $8.75 each, discounted from Wednesday's closing level of $9.21 via bookrunner Robert W. Baird & Co. Inc. and joint lead manager JMP Securities LLC.

Concord, Calif.-based Cerus is focused on systems to enhance the safety of blood supplies. The company plans to use proceeds to fund research and development, commercialization activities, clinical trials, capital expenditures, working capital and general corporate purposes, including possible acquisitions.

Issuer:Cerus Corp.
Issue:Follow-on stock offering
Gross proceeds:$39.375 million
Shares:4.5 million shares
Greenshoe:675,000 shares
Price:$8.75 per share
Joint lead managers:Robert W. Baird & Co. Inc. (bookrunner) and JMP Securities LLC.
Pricing date:March 15
Settlement date:March 22
Stock symbol:Nasdaq: CERS
Stock price:$9.21 at close March 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.